beta-alanine has been researched along with nnc 05-2090 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arisawa, M; Hayakawa, W; Ide, S; Ito, Y; Katayama, T; Kawamura, S; Kobayashi, T; Masuda, E; Minami, M; Nakada, K; Shuto, S; Suemasa, A; Yamada, S; Yoshikawa, M | 1 |
| Abe, H; Arisawa, M; Fukuda, H; Ide, S; Igawa, A; Kobayashi, T; Minami, M; Shuto, S; Suemasa, A | 1 |
2 other study(ies) available for beta-alanine and nnc 05-2090
| Article | Year |
|---|---|
Cyclopropane-based conformational restriction of GABA by a stereochemical diversity-oriented strategy: identification of an efficient lead for potent inhibitors of GABA transports.
Topics: Animals; Anticonvulsants; Brain; Cyclopropanes; GABA Modulators; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Ligands; Mice; Protein Binding; Rats; Seizures; Stereoisomerism; Structure-Activity Relationship | 2013 |
Conformationally Restricted GABA with Bicyclo[3.1.0]hexane Backbone as the First Highly Selective BGT-1 Inhibitor.
Topics: | 2014 |